Skip to main content
logo
Revvity, Inc. (RVTY)
NYSE: RVTY · Real-Time Price · USD
97.58
-0.19 (-0.19%)
At close: Dec 23, 2025, 4:00 PM EST
97.38
-0.20 (-0.20%)
Pre-market: Dec 24, 2025, 8:59 AM EST

Revenue Breakdown

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212014 - 2021
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 2014 - 2021
Discovery & Analytical Solutions Product Revenue (Pre-Q3 2022)
--
Log In
Log In
Log In
Upgrade
Discovery & Analytical Solutions Service Revenue (Pre-Q3 2022)
--
Log In
Log In
Log In
Upgrade
Total Discovery & Analytical Solutions Revenue (Pre-Q3 2022)
--
Log In
Log In
Log In
Upgrade
Total Diagnostics Revenue (Pre-Q3 2022)
1.43B1.50B
Log In
Log In
Log In
Upgrade
Revenue (Other)
3.41B1.25B
Log In
Log In
Log In
Upgrade
Revenue (Total)
4.84B2.76B
Log In
Log In
Log In
Upgrade

Revenue Breakdown 2

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212014 - 2021
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 2014 - 2021
Total Discovery & Analytical Solutions Revenue (Post-Q2 2022)
1.39B1.25B
Log In
Log In
Log In
Upgrade
Diagnostics Product Revenue (Pre-Q3 2022)
--
Log In
Log In
Log In
Upgrade
Diagnostics Service Revenue (Pre-Q3 2022)
--
Log In
Log In
Log In
Upgrade
Total Diagnostics Revenue (Pre-Q3 2022)
1.43B1.50B
Log In
Log In
Log In
Upgrade
Revenue (Total)
4.84B2.76B
Log In
Log In
Log In
Upgrade

Revenue Breakdown 3

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212014 - 2021
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 2014 - 2021
Total Diagnostics Revenue (Pre-Q3 2022)
1.43B1.50B
Log In
Log In
Log In
Upgrade
Total Product Revenue
2.31B2.34B
Log In
Log In
Log In
Upgrade
Total Service Revenue
503.59M416.82M
Log In
Log In
Log In
Upgrade
Revenue (Total)
4.84B2.76B
Log In
Log In
Log In
Upgrade

Revenue Breakdown 4

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212014 - 2021
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 2014 - 2021
Life Sciences Revenue (Pre-Q3 2022)
--
Log In
Log In
Log In
Upgrade
Applied Markets Revenue (Pre-Q3 2022)
--
Log In
Log In
Log In
Upgrade
Revenue (Total)
4.84B2.76B
Log In
Log In
Log In
Upgrade

EBIT

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212014 - 2021
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 2014 - 2021
Discovery & Analytical Solutions Operating Income (Pre-Q3 2022)
--
Log In
Log In
Log In
Upgrade
Operating Income (Total)
363.64M346.74M
Log In
Log In
Log In
Upgrade

EBIT 2

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212014 - 2021
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 2014 - 2021
Discovery & Analytical Solutions Operating Income (Post-Q2 2022)
453.14M448.02M
Log In
Log In
Log In
Upgrade
Diagnostics Operating Income (Pre-Q3 2022)
351.23M373.19M
Log In
Log In
Log In
Upgrade
Operating Income (Total)
363.64M346.74M
Log In
Log In
Log In
Upgrade

EBIT 3

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212014 - 2021
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 2014 - 2021
Diagnostics Operating Income (Pre-Q3 2022)
351.23M373.19M
Log In
Log In
Log In
Upgrade
Operating Income (Total)
363.64M346.74M
Log In
Log In
Log In
Upgrade
Updated Oct 27, 2025. Data Source: Fiscal.ai.